WayneRussellGodfreyMD

PubMed

• 232 citations
  Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.
  Wayne R. Godfrey, Darrin J. Spoden, Ying G. Ge, Seth R. Baker, Baoling Liu, Bruce L. Levine, Carl H. June, Bruce R. Blazar, Stephen B. Porter> ;Blood. 2004 Nov 16
• 13 citations
  Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma.
  Sven de Vos, Nina D. Wagner-Johnston, Steven Coutre, Ian W. Flinn, Marshall T. Schreeder, Nathan Fowler, Jeff P. Sharman, Ralph V. Boccia, Jacqueline C. Barrientos, Ka...> ;Blood Advances. 2016 Dec 13
• 205 citations
  A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
  Brad S. Kahl, Stephen E. Spurgeon, Richard R. Furman, Ian W. Flinn, Steven Coutre, Jennifer R. Brown, Don M. Benson, John C. Byrd, Sissy Peterman, Yoonjin Cho, Albert ...> ;Blood. 2014 May 29
• 175 citations
  Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma.
  Ian W. Flinn, Brad S. Kahl, John P. Leonard, Richard R. Furman, Jennifer R. Brown, John C. Byrd, Nina D. Wagner-Johnston, Steven Coutre, Don M. Benson, Sissy Peterman,...> ;Blood. 2014 May 29
• 818 citations
  PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
  Ajay K. Gopal, Brad S. Kahl, Sven de Vos, Nina D. Wagner-Johnston, Stephen J. Schuster, Wojciech Jurczak, Ian W. Flinn, Christopher R. Flowers, Peter Martin, Andreas V...> ;The New England Journal of Medicine. 2014 Mar 12
• 713 citations
  Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
  Philip W. Kantoff, T. Schuetz, Brent A. Blumenstein, L. Michael Glode, David L. Bilhartz, Michael S. Wyand, Kelledy Manson, Dennis Panicali, Reiner Laus, Jeffrey Schlo...> ;Journal of Clinical Oncology. 2010 Mar 1
• Overall survival (OS) analysis of a phase II randomized controlled trial (RCT) of a poxviral-based PSA targeted immunotherapy in metastatic castration-resistant prosta...
  Kantoff PW, Schuetz T, Blumenstein BA, Glode MM, Bilhartz D, Gulley J, Schlom J, Laus R, Godfrey W> ;J. Clin. Oncol.. 2009-05-20
• 71 citations
  NF90 regulates inducible IL-2 gene expression in T cells
  Lingfang Shi, Wayne R. Godfrey, Joseph Lin, Guohua Zhao, Peter N. Kao> ;The Journal of Experimental Medicine. 2007 May 14
• 82 citations
  NF90 Regulates Cell Cycle Exit and Terminal Myogenic Differentiation by Direct Binding to the 3′-Untranslated Region of MyoD and p21WAF1/CIP1 mRNAs
  Lingfang Shi, Guohua Zhao, Daoming Qiu, Wayne R. Godfrey, Hannes Vogel, Thomas A. Rando, Hong Hu, Peter N. Kao> ;The Journal of Biological Chemistry. 2005 May 13
• 112 citations
  CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy.
  Lequn Li, Wayne R. Godfrey, Stephen B. Porter, Ying Ge, Carle H. June, Bruce R. Blazar, Vassiliki A. Boussiotis> ;Blood. 2004 Nov 16
• 237 citations
  In vitro–expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell–stimulated MLR cultures
  Wayne R. Godfrey, Ying G. Ge, Darrin J. Spoden, Bruce L. Levine, Carl H. June, Bruce R. Blazar, Stephen B. Porter> ;Blood. 2004 Jul 15
• 68 citations
  Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation
  Wayne R. Godfrey, Mark R. Krampf, Patricia A. Taylor, Bruce R. Blazar> ;Blood. 2004 Feb 1
• 138 citations
  Robust B Cell Immunity but Impaired T Cell Proliferation in the Absence of CD134 (OX40)
  Susanne D. Pippig, C Peña-Rossi, J Long, Wayne R. Godfrey, Deborah J. Fowell, Steven L. Reiner, M L Birkeland, Richard M. Locksley, A N Barclay, Nigel Killeen> ;Journal of Immunology. 1999 Dec 15
• 43 citations
  A response to AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family?
  Sheri Miraglia, Wayne R. Godfrey, David William Buck> ;Blood. 1998 Jun 1
• 762 citations
  A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.
  Sheri Miraglia, Wayne R. Godfrey, Amy Yin, Kristin Atkins, Roger A. Warnke, Jeannine T. Holden, Robert A. Bray, Edmund K. Waller, David William Buck> ;Blood. 1997 Dec 15
• 128 citations
  Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis.
  Adriana Weinberg, Dennis Bourdette, T.J. Sullivan, M. Lemon, J.J. Wallin, R. Maziarz, Michael P. Davey, F. Palida, Wayne R. Godfrey, Edgar G. Engleman, R.J. Fulton, Ha...> ;Nature Medicine. 1996 Feb 1
• 6 citations
  Characterization of the epitope recognized by a mAb that reacts differentially with murine suppressor T cells.
  Judith A. Kapp, Carl W. Pierce, David R. Webb, Bruce H. Devens, Wayne R. Godfrey, Satoshi Fukuse, Edgar G. Engleman, Jeffrey P. Lake, John I. Magnani, Pradip K. Maiti,...> ;International Immunology. 1995 Aug 1
• 32 citations
  Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells.
  Francesco Fagnoni, Masaru Takamizawa, Wayne R. Godfrey, A Rivas, M Azuma, K Okumura, Edgar G. Engleman> ;Immunology. 1995 Jul 1
• 238 citations
  Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor.
  Wayne R. Godfrey, Francesco Fagnoni, M A Harara, David William Buck, Edgar G. Engleman> ;The Journal of Experimental Medicine. 1994 Aug 1
• Join now to see all